CardioPractice Cardio Talk

With Mads Joensson Andersen, Aarhus University Hospital, Aarhus - Denmark and Thomas Kumler, Steno Diabetes Center, Copenhagen, Herlev -  Denmark. 
In this podcast, Mads Joensson Andersen joins Thomas Kumler to discuss chronic thromboembolic pulmonary hypertension.
REFERENCE:
1. Andersen S, Mellemkjaer S, Andersen MJ. Diagnosis and management of pulmonary hypertension due to left heart disease or pulmonary disease. CardioPractice. August 2026. https://www.escardio.org/communities/councils/cardiology-practice/education/cardiopractice/
diagnosis-and-management-of-pulmonary-hypertension-due-to-left-heart-disease-or-pulmonary-disease

With Riccardo Asteggiano, LARC (Laboratorio Analisi Ricerca Clinica), Turin - Italy and Marc Ferrini, CH Saint Joseph and Saint Luc, Lyon - France.
In this podcast, Riccardo Asteggiano joins Marc Ferrini to discuss Pulmonary hypertension due to left heart disease

With François Roubille, University Hospital Arnaud de Villeneuve, Montpellier - France and Ruxandra Christodorescu, University of Medicine and Pharmacy Victor Babes, Timisoara - Romania.
 
In this podcast, François Roubille joins Ruxandra Christodorescu  to discuss inflammation and coronary artery disease.
 
REFERENCES:
 
1.    Ridker PM, Everett BM, Thuren T, et al; CANTOS Trial Group. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. N Engl J Med. 2017;377:1119-31. https://www.nejm.org/doi/10.1056/NEJMoa1707914
 
2.    Tardif JC, Kouz S, Waters DD, et al. Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction. N Engl J Med. 2019 Dec 26;381(26):2497-2505.
https://www.nejm.org/doi/10.1056/NEJMoa1912388
 
3.    Nidorf SM, Fiolet ATL, Mosterd A, et al; LoDoCo2 Trial Investigators. Colchicine in Patients with Chronic Coronary Disease. N Engl J Med.;383:1838-1847.
https://www.nejm.org/doi/10.1056/NEJMoa2021372
 
4.    Tardif JC, Kouz S. Efficacy and safety of colchicine and spironolactone after myocardial infarction: the CLEAR-SYNERGY trial in perspective. Eur Heart J Acute Cardiovasc Care. 2024;13:843-4. https://academic.oup.com/ehjacc/article/13/12/843/7906243
 
5.    Byrne RA, Rossello X, Coughlan JJ, et al; ESC Scientific Document Group. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44:3720-826. https://academic.oup.com/eurheartj/article/44/38/3720/7243210
 
6.    Vrints C, Andreotti F, Koskinas KC, et al; ESC Scientific Document Group. 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J. 2024;45:3415-3537. https://academic.oup.com/eurheartj/article/45/36/3415/7743115

With Thomas Luscher, Royal Brompton and Harefield NHS Foundation Trust, London - UK and Marc Ferrini, CH Saint Joseph and Saint Luc, Lyon - France.
In this podcast, Thomas Luscher joins Marc Ferrini to discuss if we can still drink coffee.
 
References : 
European Prospective Investigation into Cancer and Nutrition (EPIC).  https://epic.iarc.fr/

National Health and Nutrition Examination Survey (NHANES} https://www.cdc.gov/nchs/nhanes/index.html

Luscher TF. Start your day with a morning coffee! Eur Heart J. 2025 Feb 21;46(8):760-762. https://academic.oup.com/eurheartj/article/46/8/760/7928645

Wang X, Ma H, Sun Q, Li J, Heianza Y, Van Dam RM, Hu FB, Rimm E, Manson JE, Qi L. Coffee drinking timing and mortality in US adults. Eur Heart J. 2025 Feb 21;46(8):749-759. https://doi.org/10.1093/eurheartj/ehae871https://academic.oup.com/eurheartj/article/46/8/749/7928425

Corti R, Binggeli C, Sudano I, Spieker L, Hanseler E, Ruschitzka F, Chaplin WF, Lüscher TF, Noll G. Coffee acutely increases sympathetic nerve activity and blood pressure independently of caffeine content: role of habitual versus nonhabitual drinking. Circulation. 2002 Dec 3;106(23):2935-40. https://www.ahajournals.org/doi/10.1161/01.cir.0000046228.97025.3a

With Dimitri Richter, Euroclinic of Athens, Athens - Greece and Ricardo Asteggiano, Laboratorio Analisi Ricerca Clinica, Turin - Italy.
In this podcast, Dimitri Richter joins Ricardo Asteggiano to discuss if e-cigarettes are safe.
 
REFERENCES: 
Kang D, Choi KH, Kim H, Park H, Heo J, Park TK, Lee JM, Cho J, Yang JH, Hahn JY, Choi SH, Gwon HC, Song YB. Prognosis after switching to electronic cigarettes following percutaneous coronary intervention: a Korean nationwide study. Eur Heart J. 2025;46:84-95. https://academic.oup.com/eurheartj/article/46/1/84/7828721
Münzel T, Crea F, Rajagopalan S, Lüscher T. Nicotine and the cardiovascular system: unmasking a global public health threat. Eur Heart J. 2025 Dec 18:ehaf1010. https://academic.oup.com/eurheartj/advancearticle/doi/10.1093/eurheartj/ehaf1010/8377624